Alex Gorsky has been a significant figure at Johnson & Johnson for over 30 years. He started as a sales representative and climbed the ranks to become Chairman and CEO. Under his leadership, J&J responded swiftly to the COVID-19 pandemic,...

Alex Gorsky has been a significant figure at Johnson & Johnson for over 30 years. He started as a sales representative and climbed the ranks to become Chairman and CEO. Under his leadership, J&J responded swiftly to the COVID-19 pandemic, developing a vaccine that was a game changer for public health. Gorsky is a strong advocate for health equity, committing $100 million to initiatives aimed at reducing racial inequity. He's deeply invested in the company's success, with his personal stock holdings peaking over $107 million in early 2023, showcasing his belief in J&J’s future. His compensation reflects a commitment to performance, including a notable $22.7 million in 2021, heavily tied to financial goals like operational sales and earnings growth. Now as Executive Chairman, he focuses on innovation and tackling global health challenges. Gorsky combines experience in business with a sense of responsibility towards society, transforming J&J into a leader in both healthcare and corporate responsibility.